Human CRK protein is a homolog of the chicken v-crk oncogene product and consists mostly ofsrc homology region 2 (SH2) and SH3, which are shared by many proteins, in particular those involved in signal transduction. SH2 has been shown to bind specifically to phosphotyrosine-containing peptides. We The v-crk oncogene product shares homologous amino acid sequences, designated src homology region 2 (SH2) and SH3, with many molecules involved in signal transduction (24, 45) . In addition to its transforming activity, v-crk has two particular features. (i) Cells transformed by v-crk show an elevated level of phosphotyrosine, despite a lack of tyrosine kinase activity in v-Crk protein (35, 36) . (ii) v-Crk associates with a broad range of phosphotyrosine-containing proteins (29, 37) . Both of these properties have been attributed to the SH2 of v-Crk, although some enhancing effect of SH3 on these activities has been suggested (30, 32, 38) .
Rat pheochromocytoma cell line PC12 has been widely used for studies of signal transduction by growth factors, particularly by the nerve growth factor (NGF) (17) . Upon treatment with NGF, PC12 cells stop dividing, develop an excitable membrane, increase the amount of phosphotyrosine-containing protein, grow significant neuronal processes, and acquire a sympathetic neuronal phenotype (6, 11, 12, 46) . In this NGF-triggered signaling pathway of PC12 cells, p21r' has been shown to play a pivotal role. Introduction or expression of p2lvras protein in PC12 cells induced neurite outgrowth of the cells (4, 43, 50) , and microinjection of a neutralizing anti-p21ras antibody (18, 25) or expression of dominant inhibitory mutant forms of p2lras (56) suppressed the neuronal differentiation of PC12 cells induced by NGF or fibroblast growth factor. We have shown that NGF activates p21ns by increasing the level of the p21rs-GTP complex (40) . Recently, Rozakis-Adcock et al. reported that the neuronal differentiation of PC12 cells induced by Shc, an SH2-containing protein, was also inhibited by the dominantnegative mutant form of p21ras (49) .
Here, we report that two human homologs of the v-Crk protein, designated CRK-I and CRK-II, induce neuronal differentiation of PC12 cells through activation of p2lras and that intermolecular associations mediated by both SH2 and SH3 may be required for this signaling.
MATERIALS AND METHODS
Cell culture. PC12 rat pheochromocytoma cells were cultured on 35-mm-diameter dishes precoated with 10 ,ug of poly-D-lysine per ml in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum and 5% horse serum at 37°C in a humidified atmosphere of 5% CO2. 3A8, were produced and characterized in our laboratory (31) . Both MAbs were found to be specific to the SH2 of the CRK protein; however, only AD2 blocked the binding of SH2 to phosphotyrosine-containing proteins. To avoid the possible effect of the constant region of immunoglobulin, fragments of the variable region of antibodies were prepared by papain digestion. Anti-p21ras rat MAb Y13-259 (54) and an anti-vesicular stomatitis virus mouse MAb (42) were also used.
Reagents. NGF (Takara Shuzo, Kyoto, Japan) was used at 50 ng/ml to induce neurite outgrowth of PC12 cells.
Construction of expression plasmids. Molecular cloning of two alternatively spliced cDNAs of the CRK gene, CRK-I and CRK-II, has been described previously (33) . CRK-II has an extra SH3 at the carboxyl terminus, which was designated SH3(C) to distinguish it from that of the amino terminus, designated SH3(N). pGEX-CRK-I and pGEX-CRK-II were derived from pGEX2T (53) , contained the CRK-I and CRK-II coding regions downstream of the glutathione S-transferase (GST) gene, and were used to make fusion proteins.
Expression plasmids for mutant CRK proteins were constructed by a combination of restriction enzyme cleavage, fragment preparation, and ligation together with site-directed mutagenesis. All of the mutant proteins were expressed as GST fusion proteins. The nucleotide sequences and deduced amino acid sequences of wild-type CRK-I (amino acids [aa] 1 to 204) and CRK-II (aa 1 to 304) have already been described (33) . The amino acid sequences present in the mutant CRK proteins are as follows: CRK-IIdSH3(N), aa 1 to 121 and 230 to 304; CRK-I-SH2, aa 1 to 120; CRK-I-SH3(N), aa 121 to 204; CRK-II-SH3(C), aa 230 to 304; CRK-I-PST, aa 1 to 28 and 124 to 204; CRK-I-KPN, aa 1 to 177; CRK-I-SAL, aa 1 to 159; CRK-I-BGL, aa 1 to 150. Four mutants were directed to substitute four of the most conserved amino acids among the SH2s and SH3s. In CRK-I-V38, Arg-38 was changed to Val; in CRK-I-L94, Phe-94 was changed to Leu; in CRK-I-K150, Asp-150 was changed to Lys; in CRK-I-L169, Trp-169 was changed to Leu. In the other mutant proteins, clusters of basic amino acids in SH3 were substituted to abolish possible ionic interaction with other molecules. These substitutions are as follows: in CRK-I-MVL, Arg-120 to Met, Ser-121 to Val, and Arg-122 to Leu; in CRK-I-TQ, Lys-154 to Thr and Lys-155 to Gln; in CRK-I-QVQ, Arg-160 to Gln, Arg-162 to Val, and Lys-164 to Gln; in CRK-I-TT, Lys-178 to Thr and Arg-179 to Thr.
The SH3s of the mutant CRK proteins (aa 102 to 204) were also expressed as GST fusion proteins. We have previously described the v-Crk chimeras containing the SH3s of v-Src and phosphatidylinositol-specific phospholipase C-yl (PLC--yl) (32) . The SH3s of these mutant proteins (aa 102 to the carboxyl-terminal end) were similarly expressed as fusion proteins. The expression vector that encodes the SH3 of the p85 subunit of phosphatidylinositol 3-kinase (p85-SH3) has been previously described (57) .
Purification of CRK peptides. Expression and purification of GST-CRK fusion proteins have been described previously (33) . Briefly, CRK proteins were expressed in Escherichia coli DH5a, solubilized in phosphate-buffered saline (PBS) containing 1% Triton X-100, purified by glutathioneSepharose column chromatography (Pharmacia), and dialyzed against PBS. Microinjection. Microinjection was performed with an automated injection system (Zeiss). PC12 cells were injected with 0.5 pl of a protein solution as described previously (3). At 24 h after injection, photographs were taken to include both injected cells (left) and noninjected cells (right). Magnification, x200.
Cells were fixed at 24 h after microinjection and probed with an anti-GST MAb as described below. Positive cells were counted as successfully injected cells, and the number of PC12 cells which extended neurites longer than the diameter of the cell body were counted as differentiated cells.
Immunocytochemistry. Cells were fixed with 4% paraformaldehyde in PBS at 37°C for 15 min, permeabilized with 0.2% Triton X-100 in PBS at room temperature for 3 min, probed with a MAb for 1 h, washed with PBS three times, and incubated with a fluorescein isothiocyanate-conjugated antimouse immunoglobulin antibody for 1 h. A fluorescein isothiocyanate-conjugated anti-rat immunoglobulin antibody was used for detection of injected anti-p21las MAb Y13-259. Cells were observed by fluorescence-activated or confocal microscopy (Bio-Rad).
Detection of the SH3-binding protein. Total lysates of PC12 cells were separated on sodium dodecyl sulfate (SDS)-polyacrylamide gels and transferred onto a polyvinylidene difluoride membrane. Nonspecific binding of the filters was blocked by 2% skim milk in PBS containing 0.05% Tween 20 for 12 h at 4°C. The filters were incubated with 2 ,ug of SH3 peptides per ml in PBS-0.05% Tween 20 for 2 h at 25°C. After being washed in PBS-0.05% Tween 20, bound peptides were detected by successive incubation with an anti-GST MAb, an alkaline phosphatase-conjugated anti-mouse immunoglobulin antibody, and 5-bromo-4-chloro-3-indolylphosphate toluidinium (salt)-nitroblue tetrazolium (BCIP-NBT).
RESULTS
Neurite outgrowth of PC12 cells induced by CRK protein.
We microinjected PC12 cells with the CRK-I protein expressed in E. coli as a GST fusion protein. The We microinjected a series of mutant CRK proteins to define the region required for CRK-mediated neuronal differentiation of PC12 cells. Figure 3 (Fig. 4 ). These results demonstrate that both SH2 and SH3(N) are required for induction of neurite outgrowth of PC12 cells. MVL, QVQ, and TT were fully active in the induction of neurite outgrowth, suggesting that the amino acids substituted in these mutant proteins were not directly involved in CRK-induced neurite outgrowth.
Competition of CRK-I-induced neurite outgrowth by SH3 peptides. Although some reports have suggested that SH3 binds to cellular proteins (7, 9, 13, 24, 41, 45) corresponding SH3(N) peptides to compete with CRK-I. In contrast, a mutation in TT affected neither its ability to induce neurite outgrowth nor the capacity of the corresponding SH3(N) to compete with CRK-I. These results strongly suggest that binding of SH3(N) to other cellular factors was required for neuronal differentiation of PC12 cells by CRK-I. We examined the specificity of the interaction mediated by SH3(N) by introducing SH3(C) and the SH3s of the other proteins: v-Src, PLC-yl, and the p85 subunit of phosphatidylinositol 3-kinase (Table 1 ). The SH3 peptides of SH3(C), v-Src, and p85 did not decrease the ratio of the differentiated cells to the same extent as did the SH3(N) of CRK. We could not concentrate the SH3 peptide of PLC--yl to more than 3 mg/ml; therefore, a clear result was not obtained with this peptide.
Binding of SH3 peptides to cellular proteins. We searched for the targets of CRK SH3 by performing a filter-binding assay. Proteins from PC12 cells were probed with the VOL. 13, 1993 on Fig. 5A and  B) . By comparing the proteins detected with GST alone and with peptides containing CRK SH3(N), we found that three proteins, of 118, 125, and 136 kDa, bound specifically to CRK SH3(N) (Fig. 5A, lanes 3, 4, and 6 ). These proteins were in the cytoplasmic fraction after subcellular fractionation (data not shown).
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SH3(N) peptides of CRK-I and its mutant forms (
The binding of mutant SH3s to these three proteins correlated well with the capacity of corresponding CRK-I proteins to induce neurite outgrowth in PC12 cells. The SH3s of QVQ (Fig. 5A, 
DISCUSSION
The CRK protein belongs to a newly emerging class of proteins that are thought to play an important role in signal transduction from tyrosine kinases. These proteins, CRK, Nck (26) , and GRB2/ASH/Sem-5 (10, 28, 34) , consist mostly of SH2s and SH3s, the number and arrangement of which vary in each protein. A genetic study with C. elegans revealed that the sem-5-encoded protein acts upstream of a let-60-encoded Ras-like protein and downstream of a let-23-encoded epidermal growth factor receptor-like protein in vulval formation (10) . Moreover, human GRB2 promoted cell growth under overexpression of the H-Ras protein (28) and antisense RNA of mouse ASH inhibited cell replication (34) . Our results demonstrate that the CRK protein also transduces signals by activating p2l"as. Therefore, this group of proteins appears to have the common property of activating Ras family proteins. Recently, the 3BP-1 protein, which has homology to GTPase-activating protein for rho, was identified as a protein bound to the SH3 of c-Abl, suggesting a direct or indirect link of the SH3-containing protein to the Ras and Ras-like proteins (9) .
An excess amount of the peptide covering SH3(N) inhibited CRK-induced neuronal differentiation of PC12 cells. This implies the presence of a limited amount of the targets of the CRK SH3(N) domain in PC12 cells. Because the neurite formation induced by p2l'ras or NGF was not inhibited by CRK-SH3(N) (data not shown), the inhibition was specific to CRK-induced neurite formation. Mutations of SH3(N) which impaired the capacity of the CRK protein to induce neuronal cell differentiation also abolished the inhibitory effect of the corresponding SH3(N) peptides on CRK-I-induced neurite formation. These results suggested that SH3 transduces a signal through direct binding to cellular targets. Lack of inhibition of CRK-induced neuronal cell differentiation by SH3(C) and SH3 of v-Src, PLC--yl, and the p85 subunit of phosphatidylinositol 3-kinase indicated that the intermolecular association mediated by SH3 is specific to each SH3, as is the case with SH2 (14, 24, 30) . In agreement with the findings described above, we identified three proteins, of 118, 125, and 136 kDa, in PC12 cells that bound specifically to CRK SH3(N). Another piece of evidence for the specificity of each SH3 has been obtained by using a v-Crk chimera containing the SH3s of v-Src, c-Src, and PLC--y (32 
